148 related articles for article (PubMed ID: 15011629)
1. FDA notifications. UCB Pharma and FDA issue advisory letter.
AIDS Alert; 2004 Feb; 19(2):22-4. PubMed ID: 15011629
[No Abstract] [Full Text] [Related]
2. FDA notifications. Abbott sends out provider letter about Kaletra for kids.
AIDS Alert; 2007 Oct; 22(10):118. PubMed ID: 18416010
[No Abstract] [Full Text] [Related]
3. FDA notifications. Kaletra revisions to packaging approved.
AIDS Alert; 2010 Mar; 25(3):34. PubMed ID: 20629261
[No Abstract] [Full Text] [Related]
4. FDA notifications. FDA approves new dosing for Kaletra.
AIDS Alert; 2010 Jun; 25(6):70-1. PubMed ID: 20623833
[No Abstract] [Full Text] [Related]
5. FDA notifications. FDA approves half-strength Kaletra.
AIDS Alert; 2008 Jan; 23(1):10. PubMed ID: 18572474
[No Abstract] [Full Text] [Related]
6. FDA notifications. HIV-1 adult treatment guidelines are updated.
AIDS Alert; 2006 Jun; 21(6):71. PubMed ID: 16795141
[No Abstract] [Full Text] [Related]
7. Kaletra OK'd by FDA.
James JS
Posit Living; 2000 Nov; 9(9):8, 13. PubMed ID: 12154764
[No Abstract] [Full Text] [Related]
8. FDA notifications. Generic lopinavir/ritonavir approved by FDA.
AIDS Alert; 2009 May; 24(5):59. PubMed ID: 19452652
[No Abstract] [Full Text] [Related]
9. FDA notifications. FDA approves new Kaletra formulation.
AIDS Alert; 2005 Dec; 20(12):142-3. PubMed ID: 16400722
[No Abstract] [Full Text] [Related]
10. FDA notifications. BMS issues letter about omeprazole.
AIDS Alert; 2005 Apr; 20(4):45-6. PubMed ID: 15841529
[No Abstract] [Full Text] [Related]
11. Once-daily dosing of lopinavir/ritonavir (Kaletra) receives FDA approval.
AIDS Patient Care STDS; 2010 Jun; 24(6):395. PubMed ID: 20575157
[No Abstract] [Full Text] [Related]
12. Drug interactions. Kaletra and ezetimibe.
TreatmentUpdate; 2006; 18(3):8. PubMed ID: 17209242
[No Abstract] [Full Text] [Related]
13. FDA notifications. Tibotec issues Dear Health Care Professional letter.
AIDS Alert; 2008 Apr; 23(4):48. PubMed ID: 19253457
[No Abstract] [Full Text] [Related]
14. [New generation protease inhibitor. Tolerance and potency, a tight association].
MMW Fortschr Med; 2000; 142(3 Suppl):40-1. PubMed ID: 10893967
[No Abstract] [Full Text] [Related]
15. FDA notifications. Agenerase product label changed.
AIDS Alert; 2002 Oct; 17(10):131. PubMed ID: 12400469
[No Abstract] [Full Text] [Related]
16. FDA notifications. FDA approves NDA for Lexiva.
AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415960
[No Abstract] [Full Text] [Related]
17. New Norvir soft-gel capsule formulation approved by FDA.
Gaylord G
Posit Living; 1999 Aug; 8(7):11. PubMed ID: 12492076
[No Abstract] [Full Text] [Related]
18. FDA notifications. PIs have new drug-drug interaction language.
AIDS Alert; 2010 Jun; 25(6):71-2. PubMed ID: 20623834
[No Abstract] [Full Text] [Related]
19. FDA notifications. Alternative dosing regimen for atazanavir is approved.
AIDS Alert; 2008 Nov; 23(11):129-30. PubMed ID: 19048649
[No Abstract] [Full Text] [Related]
20. Drug interactions. Kaletra and atazanavir.
TreatmentUpdate; 2006; 18(3):7-8. PubMed ID: 17211919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
